Lula starts radiation treatment after early-stage skin cancer diagnosis

Brazilian President Luiz Inacio Lula da Silva has begun a preventive course of radiation therapy after doctors removed a scalp lesion that was identified as early-stage basal cell carcinoma, a common skin cancer linked to sun exposure. Hospital Sírio-Libanês said the treatment will be superficial radiotherapy on the scalp, and the presidency said the lesion was small. Doctors said Lula can continue his daily activities without restrictions.

The April 24 procedure in Bela Vista, São Paulo, was described as having no complications, and Lula was discharged the same day. The visit also included an injection in his right wrist to treat tenosynovitis. Cardiologist Roberto Kalil Filho said the healing period would take about one month and that there were no medical restrictions on campaigning.

The diagnosis carries political weight because Lula is 80, Brazil’s oldest sitting president, and his medical record already includes serious episodes. In 2024, he underwent emergency surgery to treat and prevent bleeding in his head. In 2011, he was treated for throat cancer. That history makes each new health update part of the wider conversation about how long Lula can sustain the travel, public appearances and decision-making required of a president in a large and polarized country.

That question matters even more with Brazil heading toward the 2026 election cycle. The Superior Electoral Court has set the first round for October 4, 2026, with a possible runoff on October 25. Lula said on October 23, 2025, that he would seek reelection for a fourth non-consecutive term, and polling has shown him leading right-wing challenger Flavio Bolsonaro in a potential runoff. Jair Bolsonaro remains out of the field because of legal problems and ineligibility, leaving the right still searching for a viable path.

For Lula, the immediate governance issue is not the diagnosis itself but whether treatment interrupts the presidential routine. If the course remains simple and his schedule stays intact, the operational impact may be limited. If appointments, travel or fatigue force any slowdown, the effect would reach beyond medicine into coalition management, market sentiment and the left’s succession planning. In Brazil, a sitting president’s health is never only a private matter; it is part of the machinery of state.